JPH0534339B2 - - Google Patents

Info

Publication number
JPH0534339B2
JPH0534339B2 JP59203273A JP20327384A JPH0534339B2 JP H0534339 B2 JPH0534339 B2 JP H0534339B2 JP 59203273 A JP59203273 A JP 59203273A JP 20327384 A JP20327384 A JP 20327384A JP H0534339 B2 JPH0534339 B2 JP H0534339B2
Authority
JP
Japan
Prior art keywords
compound
cancer metastasis
cancer
formula
metastasis inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59203273A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6183125A (ja
Inventor
Isao Suda
Satoshi Toyoshima
Toshiaki Oosawa
Masayoshi Ito
Yoshasu Shidori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANTO ISHI PHARMA CO Ltd
Original Assignee
KANTO ISHI PHARMA CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANTO ISHI PHARMA CO Ltd filed Critical KANTO ISHI PHARMA CO Ltd
Priority to JP20327384A priority Critical patent/JPS6183125A/ja
Publication of JPS6183125A publication Critical patent/JPS6183125A/ja
Publication of JPH0534339B2 publication Critical patent/JPH0534339B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP20327384A 1984-09-28 1984-09-28 癌転移阻害剤 Granted JPS6183125A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20327384A JPS6183125A (ja) 1984-09-28 1984-09-28 癌転移阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20327384A JPS6183125A (ja) 1984-09-28 1984-09-28 癌転移阻害剤

Publications (2)

Publication Number Publication Date
JPS6183125A JPS6183125A (ja) 1986-04-26
JPH0534339B2 true JPH0534339B2 (enExample) 1993-05-21

Family

ID=16471314

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20327384A Granted JPS6183125A (ja) 1984-09-28 1984-09-28 癌転移阻害剤

Country Status (1)

Country Link
JP (1) JPS6183125A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
US10624926B2 (en) 2014-01-14 2020-04-21 Luterion Co., Ltd. Luterial and method for isolating and culturing the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3787403D1 (de) * 1986-05-09 1993-10-21 Pulverer Gerhard Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore.
KR19980703698A (ko) * 1996-02-08 1998-12-05 모리따 겐조 암 전이 억제 항암제 물질
US8940719B2 (en) 2006-07-03 2015-01-27 Academia Sinica Lithocholic acid analogues that inhibit sialyltransferase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019917B2 (ja) * 1981-05-22 1985-05-18 関東医師製薬株式会社 Ｎ―アセチルノイラミン酸誘導体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
US10624926B2 (en) 2014-01-14 2020-04-21 Luterion Co., Ltd. Luterial and method for isolating and culturing the same

Also Published As

Publication number Publication date
JPS6183125A (ja) 1986-04-26

Similar Documents

Publication Publication Date Title
JP5357857B2 (ja) 抗ガン剤及びｄｎａ複製阻害剤
HU228064B1 (en) New antiviral nucleoside derivatives
JPH01501628A (ja) ヒト免疫不全ウイルスの細胞毒性作用に対して有効な酸安定性ジデオキシヌクレオシド
EP3546450A1 (en) Piperidine-2,6-dione derivative and treatment for ulcerative colitis
JPH0534339B2 (enExample)
JP6588341B2 (ja) 転移抑制活性を有するリン含有糖アナログ複素環
CN101402667B (zh) 糖基化修饰的一氧化氮供体型齐墩果酸类化合物、其制备方法及用途
US4650785A (en) Pharmaceutical composition having an excellent absorption property
JPH08503699A (ja) 全身性炎症と炎症性肝炎の治療のためのピリミジンヌクレオチド前駆体
US4239905A (en) 1-β-D-Arabinofuranosylcytosine-5'-oleyl phosphate and salts thereof
PT88568B (pt) Processo para a preparacao de derivados de sacaridos
KR880001869B1 (ko) 2-β-D-리보푸라노실셀레나졸-4-카르복사미드화합물의 제조방법
JPS59204175A (ja) ５―フルオロウラシル誘導体を有効成分とする血小板凝集抑制剤
CN110573620A (zh) 血癌治疗剂
JPH0421694A (ja) 新規なヌクレオシド―リン脂質複合体
JP3667359B2 (ja) ５−フルオロウリジン誘導体の製造および医薬組成物
JP2528370B2 (ja) 抗腫瘍剤
JPH0577649B2 (enExample)
JPS6144897A (ja) ５−フルオロウラシル誘導体およびこれを含有する医薬製剤
WO2015027669A2 (zh) 苯基取代化合物及其药物组合物和应用
JPH0684307B2 (ja) 新規癌転移阻害剤
CN103694248B (zh) 从藤黄中提取的抗肿瘤化合物及其制备方法与用途
CN105085614B (zh) 一种链丝菌素甲磺酸钠及其制备方法和用途
JPH03115223A (ja) 癌転移阻害剤
CN109528664B (zh) 含乌苯美司-抗肿瘤药物协同前药衍生物的冻干粉剂及其制备方法